Healiva SA is a patient‑centric biotech company developing personalized therapies for chronic wound care. It combines cell therapies, enzyme technology and medical devices and is developing products such as EpiDex (epidermal cell graft), AQUAtryp (enzymatic debriding agent), Healiva 002 (allogeneic cell spray) and Healiva 004 (autologous blood patch) for hard‑to‑heal wounds.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
✓ Offered
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Personalized, affordable therapies for chronic wounds; development of cell therapies, enzyme technology and medical products for wound care and wound healing.
Epidermal cell graft (Epidex®)
Personalized treatment for severe chronic wounds; epidermal cell graft approach for severe chronic wounds and VLUs.
Enzymatic debridement (AQUAtryp / Healiva 003)
Enzymatic debridement agent for acute and chronic wounds; low-pain, easy to use and intended for wound cleansing and preparation.
Allogeneic cell spray therapy (Healiva 002)
Allogeneic cell spray to stimulate growth factors; for chronic wounds, in particular VLU, with scalability for many patients.